arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

ENDRA Life Sciences Inc.

NDRA

$4.50 ▲ +0.37 (+8.82%) at close

10 Visible periods

26 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, ENDRA Life Sciences Inc. shows weak fundamentals, weighed down by Return on Invested Capital and Interest Coverage. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $3.5M

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -201.4% ↗

FCF / Share $-6.61

Trailing P/E —

Price / Book 2.3x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

10-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-7.03M

↑ +38.9% —

Long-Term Debt Long-term obligations

$0.00

— —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Invested CapitalReturn on Invested Capital of -201.4% is weak on an absolute basis (target > 10%)
Interest CoverageInterest Coverage of -103.19x is weak on an absolute basis (target > 5x)
FCF / Net IncomeFCF / Net Income of 0.74x is caution on an absolute basis (target > 1x)

Health Breakdown

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	—	N/M	-98.2% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1328%)	-31.8% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-498%)	—
EPS Growth YoY (%)	—	—	—	17.8% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	38.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-14.4% Weak ↓ Weak Declining Year-over-year change in net income	23.7% Good ↑ Good Improving Year-over-year change in net income	-17.3% Weak ↓ Weak Declining Year-over-year change in net income	4.2% Caution ↑ Caution Improving Year-over-year change in net income	11.9% Fair ↑ Fair Improving Year-over-year change in net income	-35.8% Weak ↑ Weak Improving Year-over-year change in net income	-82.2% Weak Weak Year-over-year change in net income	-93.7% Weak Weak Year-over-year change in net income	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	-347.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2417%)
Effective Tax Rate (%) (%)	—	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	-255.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%
FCF / Net Income (x)	0.74x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.47x Weak Weak Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Return on Invested Capital (%)	-201.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-422.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-185.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-173.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-101.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-160.4% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-227.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-144.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-87.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	200.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%
Return on Capital (%) (%)	-149.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-243.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-155.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-141.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-89.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-131.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-151.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-124.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-75.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-365.1% Weak Weak Operating profit relative to total assets Optimal: > 10%
Return on Common Equity (%) (%)	—	—	-177.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1285%)	-182.9% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1320%)	-104.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-794%)	-163.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1190%)	-279.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1963%)	-156.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1145%)	-101.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-779%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Debt to Equity (x)	—	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.01x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-99%)	0.05x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	0.05x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	—	—	—	—	—
Interest Coverage (x)	-103.19x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-338.99x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-233.87x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-222.58x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-199.43x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-5990.58x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-225.00x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3125.71x Weak Weak Operating income divided by interest expense Optimal: > 5x	-24.89x Weak Weak Operating income divided by interest expense Optimal: > 5x
Net Debt (USD)	—	$0.00	$28.48K	$365.92K	$546.63K	—	—	—	—	—
Debt / EBITDA (x)	—	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.03x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.05x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Basic EPS, GAAP (USD)	$-8.93	—	—	$-4.56	$-5.55	—	—	—	—	—
Free Cash Flow per Share (USD)	$-6.61	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$1.92	$4.77	—	$2.27	$5.07	$0.21	$0.57	$0.84	$1.34	$-1.24
Tangible Book Value per Share (USD)	$1.92	$4.77	—	$2.27	$5.07	$0.21	$0.57	$0.84	$1.34	$-1.24
Basic Weighted Avg Shares (shares)	787,020	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Working Capital (USD)	$217.01K	$2.83M	$2.13M	$6.82M	$10.55M	$7.23M	$4.46M	$5.97M	$5.03M	$-1.19M
LT Debt (USD)	—	$0.00	$0.00	$365.92K	$546.63K	—	—	—	—	—
Total Equity (USD)	$2.26M	$2.56M	$5.66M	$7.20M	$10.78M	$7.17M	$4.76M	$6.25M	$5.28M	$-893.77K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	$0.00	$0.00	$6.17K	$351.62K	$515.58K
Depreciation Expense (USD)	$44.05K	$46.49K	$123.73K	$96.66K	$116.24K	$99.34K	$80.58K	$68.32K	$61.48K	$64.94K
Net Income, GAAP (USD)	$-7.03M	$-11.51M	$-10.06M	$-13.18M	$-11.23M	$-11.73M	$-13.31M	$-9.80M	$-5.38M	$-2.78M
Operating Cash Flow (USD)	$-5.18M	$-7.40M	$-9.55M	$-12.77M	$-11.12M	$-10.75M	$-8.59M	$-7.70M	$-3.30M	$-1.32M

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 41 quarters

ENDRA Life Sciences Inc.

Analytical Summary

10-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare NDRA with peers